SCHEMBL8089968

SCHEMBL8089968

O=C(Nc1ccc(Cl)c(Cl)c1)NS(=O)(=O)C1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.57
EPHX1 P07099 2/20 0.57
CA2 P00918 2/20 0.53
CA9 Q16790 2/20 0.53
CA4 P22748 1/20 0.53
CA5A P35218 1/20 0.53
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
NPC1 O15118 4/20 0.51
HTT P42858 3/20 0.51
LMNA P02545 2/20 0.51
ADORA3 P0DMS8 1/20 0.51
CHRM1 P11229 1/20 0.51
SLC6A2 P23975 1/20 0.51
PDE4A P27815 1/20 0.51
ADRA1A P35348 1/20 0.51
OPRM1 P35372 1/20 0.51
PDE3A Q14432 1/20 0.51
NLRP3 Q96P20 1/20 0.51
P2RY1 P47900 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8095056 0.97 EPHX2 (0.54) EPHX2EPHX1CA2CA9CA4
SCHEMBL8095054 0.97 EPHX2 (0.54) EPHX2EPHX1CA2CA9CA4
SCHEMBL8083387 0.84 RAB9A (0.57) EPHX1CA2CA9MEN1KMT2A
SCHEMBL8089942 0.83 RAB9A (0.56) EPHX1CA2CA9MEN1KMT2A
SCHEMBL8095024 0.83 RAB9A (0.60) EPHX1CA2CA9MEN1KMT2A
SCHEMBL8091184 0.78 RAB9A (0.57) EPHX1CA2CA9MEN1KMT2A
SCHEMBL8091213 0.78 RAB9A (0.57) EPHX1CA2CA9CA4MEN1
SCHEMBL19505872 0.78 ACP1 (0.57) EPHX2EPHX1CA2CA9MEN1
SCHEMBL2753185 0.77 RAB9A (0.74) EPHX2EPHX1MEN1KMT2ANPC1
SCHEMBL6466718 0.77 EPHX1 (0.58) EPHX2EPHX1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed